What are the objective criteria for weaning and extubating an adult intensive‑care patient on mechanical ventilation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Extubation Weaning Criteria for Adult ICU Patients

Extubate adult ICU patients when they pass a 30-minute spontaneous breathing trial (SBT) using pressure support 5–8 cm H₂O with PEEP 5 cm H₂O, demonstrate adequate oxygenation (SpO₂ >90% on FiO₂ ≤0.40–0.50), maintain hemodynamic stability without vasopressors, show an awake mental status with intact airway reflexes, and have a rapid shallow breathing index (RSBI) ≤105 breaths/min/L. 1, 2

Daily Readiness Screening Criteria

Before attempting any weaning trial, verify that all of the following criteria are met:

  • Resolution or marked improvement of the underlying condition that necessitated mechanical ventilation 1, 2
  • Adequate oxygenation: FiO₂ <0.50 with SpO₂ >90%, PaO₂/FiO₂ ratio ≥200 1, 2
  • Low ventilatory requirements: PEEP ≤5 cm H₂O, respiratory rate <30 breaths/min 1, 2
  • Hemodynamic stability: no active myocardial ischemia, minimal or no vasopressor support 1, 2
  • Adequate mental status: patient arousable and able to follow simple commands (open eyes, squeeze hand) 1, 2
  • Intact airway reflexes with effective cough on suctioning 1, 2
  • No new potentially serious conditions or planned procedures in the next 12–24 hours 1
  • RSBI ≤105 breaths/min/L measured after 30–60 minutes of spontaneous breathing 1

Critical pitfall: Do not commence weaning when PaO₂ <55 mm Hg on FiO₂ ≥0.40, as the probability of weaning failure is markedly increased. 1

Conducting the Spontaneous Breathing Trial

Preferred SBT Method

Use pressure support ventilation (5–8 cm H₂O) with PEEP 5 cm H₂O rather than a T-piece for the initial SBT. 1, 2 This approach increases SBT success from 76.7% to 84.6% and extubation success from 68.9% to 75.4%, with a trend toward lower ICU mortality (8.6% vs 11.6%). 1

SBT Settings

  • Pressure support: 5–8 cm H₂O 1, 2
  • PEEP: 5 cm H₂O 1, 2
  • FiO₂: ≤0.40 (40%) 1, 2
  • Duration: 30 minutes for standard-risk patients; 60–120 minutes for high-risk patients 1, 2, 3

Rationale: The modest pressure support overcomes endotracheal tube resistance without masking readiness, while PEEP maintains alveolar recruitment and reduces work of breathing from intrinsic PEEP. 1 Most SBT failures occur within the first 30 minutes. 1, 2

SBT Failure Criteria (Stop Immediately If Any Occur)

  • Respiratory distress: respiratory rate >35 breaths/min or increasing trend, accessory muscle use, abdominal paradox 1, 2
  • Oxygen desaturation: SpO₂ <90% 1, 2
  • Hemodynamic instability: heart rate >140 bpm or sustained increase >20%, systolic BP >180 mmHg or <90 mmHg 1, 2
  • Altered mental status: increased anxiety, agitation, or diaphoresis 1, 2

Important: If an SBT fails, do not repeat the trial on the same day. 3 Focus on identifying and addressing reversible causes (fluid overload, cardiac dysfunction, inadequate secretion clearance) before attempting another trial the following day. 3

Pre-Extubation Assessment Beyond the SBT

A successful SBT does not guarantee successful extubation—approximately 10% of patients who pass an SBT will still fail extubation within 48 hours. 1, 2 Therefore, assess the following additional factors:

Upper Airway Patency (Cuff-Leak Test)

  • Perform a cuff-leak test in patients with risk factors for laryngeal edema: female gender, nasal intubation, difficult/traumatic intubation, large endotracheal tube, high cuff pressures, or prolonged intubation (>7 days) 4, 2
  • Positive test: absolute leak volume ≥110 mL or relative leak volume ≥10% 2
  • If the test fails (low or absent leak), administer systemic corticosteroids (≈1 mg/kg prednisolone) at least 4–6 hours before extubation 4, 2

Airway Protection and Secretion Management

  • Bulbar function: patient must be able to protect the airway 2
  • Cough effectiveness: assess strength of cough on suctioning 1, 2
  • Secretion load: evaluate volume and character of tracheal secretions 2

Weak cough or excessive secretions are independent risk factors for extubation failure and warrant consideration of prophylactic respiratory support. 2

Neuromuscular Function (If Applicable)

  • Quantitative Train-of-Four (TOF) >90% to ensure adequate reversal of neuromuscular blockade 2

Risk Stratification for Post-Extubation Management

High-Risk Criteria for Extubation Failure

Patients are considered high-risk if they have any of the following:

  • Age >65 years with multiple comorbidities 1, 2
  • Cardiac failure as the primary cause of respiratory failure 1, 2
  • APACHE II score >12 on the day of extubation 1
  • Failure of more than one prior SBT 1, 2
  • PaCO₂ >45 mm Hg after extubation or during the SBT 1, 2
  • Presence of ≥1 comorbid condition (COPD, CHF) 1, 2
  • Weak cough or excessive secretions 1, 2
  • Prolonged mechanical ventilation (>14 days) 2
  • Neurologic impairment or neuromuscular disease 2

Post-Extubation Strategy Based on Risk

Standard-Risk Patients

  • Extubate directly to supplemental oxygen via face mask or nasal cannula 1
  • Target SpO₂ 88–92% (particularly in patients with chronic hypercapnia) 1
  • Monitor continuously for the first 24 hours: SpO₂, respiratory rate, work of breathing 1

High-Risk Patients

Apply prophylactic noninvasive ventilation (NIV) within 1 hour of extubation. 1, 2 This approach reduces:

  • Re-intubation risk (RR 0.61; 95% CI 0.48–0.79) 1
  • ICU mortality (RR 0.54; 95% CI 0.41–0.70) 1
  • ICU length of stay by approximately 2.5 days 1

NIV settings: IPAP 10–12 cm H₂O, EPAP 5–10 cm H₂O, titrate FiO₂ to maintain SpO₂ 88–92% 1

Alternative for hypoxemic patients: High-flow nasal cannula (HFNC) lowers re-intubation rates to 4% versus 21% with conventional oxygen (P=0.01). 1

Known Difficult Airway

  • Schedule extubation during daytime hours with experienced personnel immediately available 2
  • Consider an airway exchange catheter left in place after extubation for patients at high risk of difficult re-intubation 2
  • The catheter facilitates re-intubation within 10 hours and should be removed no later than 24 hours after placement 2

Protocol-Driven Weaning Approach

Implement a standardized weaning protocol led by respiratory therapists or nurses, with physician sign-off only for the final extubation decision. 1 This approach:

  • Reduces total mechanical ventilation duration by approximately 25 hours 1
  • Shortens ICU length of stay by approximately 1 day 1
  • Increases overall weaning success rates 1

Definition of Successful Extubation

Extubation is considered successful when the patient does not require re-intubation or NIV within 48 hours post-extubation. 1, 2, 3 An extubation failure rate of 5–10% is acceptable in contemporary ICU practice. 4, 2

Critical Pitfalls to Avoid

  • Do not delay extubation in patients who pass their first SBT, are <65 years, have normal PaCO₂, and lack significant respiratory or cardiac comorbidities—they rarely require prophylactic NIV 1
  • Do not use SIMV for weaning—it is inferior to pressure support and T-piece methods 1, 3
  • Do not rely solely on the SBT—screen for upper airway obstruction, ineffective cough, excessive secretions, swallowing disorders, and altered consciousness 4, 2
  • Do not extubate patients still requiring vasopressors or with unresolved primary pathology 1
  • Avoid premature weaning when using pressure-supported SBTs, as they may underestimate post-extubation work of breathing 3

Consequences of Extubation Failure

  • Failed extubation is associated with 10–20% higher mortality compared with successful extubation 2, 5
  • Up to 15% of ICU patients require re-intubation within 48 hours 2
  • Post-extubation stridor occurs in 12–37% of extubations and accounts for approximately 15% of early re-intubations 2

References

Guideline

Weaning from Mechanical Ventilation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Criteria for Extubation from Mechanical Ventilation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

T-Piece Spontaneous Breathing Trial Duration and Criteria for Extubation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The decision to extubate in the intensive care unit.

American journal of respiratory and critical care medicine, 2013

Related Questions

What is the best approach to wean a patient off a mechanical ventilator (MV)?
What is the best approach to wean a patient off mechanical ventilation (MV)?
When should extubation (removal of the endotracheal tube) be considered in a ventilator patient?
What are the criteria for determining readiness to extubate (remove endotracheal tube) critically ill patients?
What is the recommended structured, multidisciplinary approach to prolonged weaning for a patient who has failed at least three spontaneous breathing trials (SBTs) or more than seven days of attempts after the first successful trial and has been intubated for more than ten to fourteen days?
What are the pharmacology, recommended dosing, toxicity risks, drug interactions, and contraindications of multivitamin supplements in adults, including special populations such as pregnant women, chronic kidney disease, and hemochromatosis?
In a septic patient with hypoalbuminemia, how long does serum albumin typically take to normalize after adequate infection control and supportive care, and what factors influence this timeline?
What is the appropriate emergency department management for a patient with acute hypernatremia (serum sodium ≥150 mmol/L developing within the past 48 hours)?
What is the recommended initial diagnostic workup for a child suspected of having neuroblastoma?
Can a healthy adult with mild COVID‑19 use Mucinex (guaifenesin) for cough relief, and what is the appropriate dosing and contraindications?
Can low‑molecular‑weight heparin (LMWH) cause a cerebrovascular accident (CVA)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.